Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
| 6.52 Delayed Data As of Mar 24 |  +0.31 / +4.99%Today’s Change | 1.77 Today|||52-Week Range 9.22 | +137.09% Year-to-Date |
Latest VRCA News | Press Releases
No recent news for Verrica Pharmaceuticals Inc.
Today’s Trading
| Previous close | 6.21 |
| Today’s open | 6.21 |
| Day’s range | 6.21 - 6.83 |
| Volume | 15,784 |
| Average volume (3 months) | 156,755 |
| Market cap | $295.9M |
Data as of 4:00pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +44.74% |
| Earnings growth (this year) | -58.41% |
| Earnings growth (next 5 years) | -20.18% |
| Revenue growth (last year) | -24.73% |
| P/E ratio | NM |
| Price/Sales | 10.40 |
| Price/Book | 7.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| STROSutro Biopharma Inc | +0.00 | +0.11% |
| ---- | ||
| ---- | ||
| --China Health Group I... | 0.00 | 0.00% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | May 10, 2023 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $9.0M |
| Annual profit (last year) | -$24.5M |
| Net profit margin | -271.11% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters West Chester, Pennsylvania |
Forecasts
